October 30th, 2009

Study Eases Arthritis Drug Cancer Fears

By Kelley Luckstein

Rheumatoid arthritis patients who take the biologic drugs Remicade, Humira, and Enbrel do not appear to have an increased risk for developing cancer in the first few years of use, researchers in Sweden report.

 

The study is one of the largest and longest population-based investigations ever into the cancer-causing potential of the drugs, known as tumor necrosis factor (TNF) inhibitors…

 

The new findings should reassure patients, but questions remain about the short-term and long-term safety of TNF-blocking drugs, rheumatologist Eric Matteson, MD, of Mayo Clinic in Rochester, Minn., tells WebMD.

 

WebMD by Salynn Boyles, 10/29/09

Tags: arthritis, Cancer, Cancer, Rheumatology, Rheumatology

Contact Us · Privacy Policy